URS
BVS icon

Utah Retirement Systems’s Bioventus BVS Stock Holding History

Utah Retirement Systems’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-26,272
Closed -$86.7K – 989
2023
Q3 		$86.7K Buy
+26,272
New +$92.2K ﹤0.01% 962

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Utah Retirement Systems's BVS Position: Q4 2023 in Review

Utah Retirement Systems sold out of Bioventus (BVS) in Q4 2023, closing a stake of 26,272 shares — an estimated $86.7K sold.

Utah Retirement Systems first reported a position in BVS in Q3 2023 and held it in 1 quarter. The position peaked at $86.7K in Q3 2023. 80 funds tracked by Wall St. Rank hold BVS as of Q4 2023.

  • Utah Retirement Systems reported no remaining Bioventus position as of Q4 2023 after selling out during the quarter.
  • Utah Retirement Systems sold 26,272 Bioventus shares in Q4 2023, an estimated $86.7K.
  • Utah Retirement Systems first reported a position in Bioventus in Q3 2023 and held it in 1 quarter.
  • Utah Retirement Systems's Bioventus position peaked at $86.7K in Q3 2023.
  • 80 funds tracked by Wall St. Rank held Bioventus as of Q4 2023.

Based on Utah Retirement Systems's 13F filing for Q4 2023, filed 14 Feb 2024.